Difference between revisions of "Fluoxymesterone (Halotestin)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs") |
m |
||
| Line 2: | Line 2: | ||
Androgen and anabolic steroid | Androgen and anabolic steroid | ||
| − | ==Diseases for which it | + | ==Diseases for which it was used== |
*[[Breast cancer]] | *[[Breast cancer]] | ||
| Line 15: | Line 15: | ||
[[Category:Anabolic steroids]] | [[Category:Anabolic steroids]] | ||
| − | [[Category:Breast cancer medications]] | + | [[Category:Breast cancer medications (historic)]] |
[[Category:FDA approved in 1956]] | [[Category:FDA approved in 1956]] | ||
[[Category:Discontinued drugs]] | [[Category:Discontinued drugs]] | ||
Revision as of 01:06, 28 April 2022
Mechanism of action
Androgen and anabolic steroid
Diseases for which it was used
History of changes in FDA indication
- 10/15/1956: Initial FDA approval
Also known as
- Brand names: Halotestin, Ultandren